Updated NDS for pharmaceutical QA/QC offers enhanced support of IT infrastructures, extended support for fail-over clustering, and compatibility with Windows XP
Agilent Technologies has announced that it has begun shipping a new revision of the Agilent Cerity networked data system (NDS) for pharmaceutical QA/QC that provides enhanced support of IT infrastructures.
The new release features extended support of clustered fail-over configurations for database servers and client compatibility with the Microsoft Windows XP operating system.
Extended support for fail-over clustering enhances the failure resilience of the laboratory IT infrastructure and thereby increases system availability and uptime.
This is particularly important for multi-user, multi-technique laboratories that are subject to GxP regulations.
The compatibility of Cerity NDS client PCs with Windows XP enables laboratories to benefit from the advantages of Microsoft's latest operating system, including plug-and-play capability, standards-based security, a simplified user interface, and increased manageability and reliability.
The new features of this release make Cerity NDS for pharmaceutical QA/QC a failure-resilient, fully scalable, networked data system, supporting operational models such as 24x7 continuous shifts or distributed laboratory operations across different buildings, sites or countries.
Cerity NDS for pharmaceutical QA/QC provides level-4 instrument control of Agilent's networked instrumentation, including the 1100 series liquid chromatographs, the 6890 and 6850 gas chromatographs, and the 35900E dual channel interfaces.
The Agilent Cerity NDS for pharmaceutical QA/QC also provides full instrument control of GPIB-based instrumentation such as Waters Alliance systems.
The versatile, networked instrument capabilities, combined with the fully scalable client-server architecture of Cerity NDS for pharmaceutical QA/QC, make the system a perfect fit for pharmaceutical QA/QC labs.
Cerity NDS for Pharmaceutical QA/QC implements the strict technical controls required by the US Food and Drug Administration's ruling on electronic records and signatures (FDA 21 CFR Part 11) as well as other regulations and quality standards such as GMP, cGMP, Gamp, and ISO 17025.
